Teratogens
Epilepsy drugs in pregnancy can triple risk of major malformation or developmental delay in children
Published in Women's Health Weekly, May 9th, 2002
Stopping treatment for epilepsy during pregnancy is not an option, but there is an urgent need to develop safer drugs, concluded the researchers. Six in every 1000 pregnancies will be to a woman treated with epilepsy drugs.
One hundred forty-nine mothers being treated with antiepileptic drugs in the Grampian region of Scotland were studied - 58% of the total invited to take part. They had all given birth between 1976 and 2000.
In all,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Team investigating test for marker that may predict aggressive metastases - Uterine Fibroids
Extensively studied embolization equivalent to standard treatments - Genetics
Difference in P450 gene seen in lean women - Obstetrics
Excessive weight gain during pregnancy can increase breast cancer risk - Postpartum Depression
Fatty acid could improve mothers' mental health, babies' development - Teratogens
Infants exposed to cocaine prenatally have significant cognitive deficits - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
